Investing.com - Illumina reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Illumina announced earnings per share of $1.87 on revenue of $1.13B. Analysts polled by Investing.com EPS of $1.36 on revenue of $1.01B.
Illumina 's are up 39.37% and is trading at $520.00 , still down 7.22% from its 52 week high of $555.77 set on Friday, February 12, 2021.
Illumina shares gained 0.84% to trade at $520.00 in after-hours trade the report.
Illumina follows other major Healthcare sector earnings this month
Illumina's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on Thursday, July 15, 2021 with second quarter EPS of $4.7 on revenue of $71.32B, for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar